Finding Mutational Sites In Drug Resistant Strain Of Mycobacterium Tuberculosis | 17941
ISSN: 2161-1165

Epidemiology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1886

Epidemiology: Open Access received 1886 citations as per Google Scholar report

Epidemiology: Open Access peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • SafetyLit
  • Access to Global Online Research in Agriculture (AGORA)
  • Centre for Agriculture and Biosciences International (CABI)
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • CABI full text
  • Cab direct
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Finding mutational sites in drug resistant strain of Mycobacterium tuberculosis

2nd International Conference on Epidemiology & Evolutionary Genetics

Vivek Chandramohan, Manjunath Dammllai, Devashish Das Phani Kumar Puli, Lakshmi Rajesh Nare and Shumveel Quadri

Accepted Abstracts: Epidemiol

DOI: 10.4172/2161-1165.S1.009

M ycobacterium tuberculosis is an acid-fast bacterium that is responsible for causing tuberculosis. The new strains that are evolving with time are resistance to drugs currently being used for tuberculosis treatment. The study was focused on locating mutational sites of a new strain, Mycobacterium tuberculosis , using next generation sequencing techniques. In-silico genome assembly had been done to find out conserved and divergent regions of reference strains. The sequence data of the new strain was derived from public database, analyzed and assembled using both de-novo and mapping methods. The assembled sequence compares reference genome followed by gene prediction and analysis. The newly found genome is aligned with annotated reference genome to retrieve mutational sites in the new strain. The new strain shows several numbers of mutation sites at or nearby exon regions that can cause resistance to drug treatment.